21st.BIO A/S: Financial statements 2023
CVR: 41554908
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
21st.BIO A/S (CVR 41554908) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -9,825,858 and a net result of DKK -42,260,118 compared with DKK -36,612,241 the year before. Equity in the 2023 report amounted to DKK 294,808,764. The solvency ratio was 70.3%. The company had 32 employees in the financial year.
- Gross Profit
- DKK -9,825,858
- Profit/Loss
- DKK -42,260,118
- Equity
- DKK 294,808,764
- Total Assets
- DKK 419,200,435
- Employees
- 32
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -9.8 mio. | -42.3 mio. | 294.8 mio. | 32 |
| 2022 | - | -21.9 mio. | -36.6 mio. | 262.6 mio. | 11 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 1, 2023, Mikael Bechsgaard is registered as director of 21st.BIO A/S.
As of September 5, 2023, Thomas Grotkjær has joined the board of directors of 21st.BIO A/S.
As of September 5, 2023, Thomas Dal Stenfeldt Batchelor has joined the board of directors of 21st.BIO A/S.
As of September 5, 2023, Anders Bendsen Spohr has left the board of directors of 21st.BIO A/S.
As of September 5, 2023, Amy Louise Byrick has left the board of directors of 21st.BIO A/S.
21st.BIO A/S has published its annual report for 2022. Gross profit came to DKK -21,930,501, and the net result was DKK -36,612,241.
About 21st.BIO A/S
21st.BIO A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2020. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Copenhagen Bio Partners A/S. The management consists of Henrik Marcus Geertz-Hansen, Jose Arnau Martinez and Mikael Bechsgaard. The board consists of Anders Bendsen Spohr (chair), Claus Crone Fuglsang, Thomas Dal Stenfeldt Batchelor and Thomas Grotkjær. The company is owned by Novo Holdings A/S, NOVOZYMES A/S and Momentum Techinvest ApS. The company has 44 employees (2026). In 2025, the company reported a gross profit of DKK -15,518,420 and a net result of DKK -127,801,300 compared with DKK -41,660,123 the year before. Equity in the 2025 report amounted to DKK 202,530,839.